547
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Prevalence and Associated Factors of Dyslipidemia Among Adults with Type 2 Diabetes Mellitus in Saudi Arabia

ORCID Icon &
Pages 4033-4040 | Published online: 28 Oct 2020

References

  • International Diabetes Federation. IDF diabetes atlas. 6th edition. Brussels, Belgium: International Diabetes Federation; 2013. Available from: http://www.idf.org/diabetesatlas. Accessed October 22, 2020.
  • Abuyassin B, Laher I. Diabetes epidemic sweeping the Arab world. World J Diab. 2016;7:165–174. doi:10.4239/wjd.v7.i8.165
  • Meo SA. Prevalence and future prediction of type 2 diabetes mellitus in the Kingdom of Saudi Arabia: A systematic review of published studies. J Pak Med Assoc. 2016;66:722–725.
  • Palazhy S, Viswanathan V. Lipid abnormalities in type 2 diabetes mellitus patients with overt nephropathy. Diab Metab J. 2017;41:128–134. doi:10.4093/dmj.2017.41.2.128
  • Bekele S, Yohannes T, Mohammed AE. Dyslipidemia and associated factors among diabetic patients attending Durame General Hospital in Southern Nations, Nationalities, and People’s Region. Diab Metab Syndr Obes. 2017;10:265–271. doi:10.2147/DMSO.S135064
  • Bayram F, Kocer D, Gundogan K, et al. Prevalence of dyslipidemia and associated risk factors in Turkish adults. J Clin Lipidol. 2014;8:206–216. doi:10.1016/j.jacl.2013.12.011
  • Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation. 1998;97:596–601. doi:10.1161/01.CIR.97.6.596
  • Fuentes R, Uusitalo T, Puska P, et al. Blood cholesterol level and prevalence of hypercholesterolaemia in developing countries: a review of population-based studies carried out from 1979 to 2002. Eur J Cardiovasc Prev Rehabil. 2003;10(6):411–419. doi:10.1097/01.hjr.0000085247.65733.4f
  • Ni WQ, Liu XL, Zhuo ZP, et al. Serum lipids and associated factors of dyslipidemia in the adult population in Shenzhen. Lipids Health Dis. 2015;14:71. doi:10.1186/s12944-015-0073-7
  • World Health Organization (WHO). Body mass index (BMI) classification. Available from: http://apps.who.int/bmi/index.jsp. Accessed February 18, 2018.
  • Kassahun T, Eshetie T, Gesesew H. Factors associated with glycemic control among adult patients with type 2 diabetes mellitus: a cross-sectional survey in Ethiopia. BMC Res Notes. 2016;9:78. doi:10.1186/s13104-016-1896-7
  • Ahmed AM, Hersi A, Mashhoud W, et al. Cardiovascular risk factors burden in Saudi Arabia: the Africa Middle East Cardiovascular Epidemiological (ACE) study. J Saudi Heart Assoc. 2017;29:235–243. doi:10.1016/j.jsha.2017.03.004
  • Khader YS, Batieha A, El-Khateeb M, et al. Prevalence of dyslipidemia and its associated factors among Jordanian adults. J Clin Lipidol. 2010;4:53–58. doi:10.1016/j.jacl.2009.12.004
  • Turk-Adawi K, Sarrafzadegan N, Fadhil I, et al. Cardiovascular disease in the eastern Mediterranean region: epidemiology and risk factor burden. Nat Rev Cardiol. 2017. doi:10.1038/nrcardio.2017.138.
  • Elmaogullari S, Tepe D, Ucakturk SA, et al. Prevalence of Dyslipidemia and associated factors in obese children and adolescents. J Clin Res Pediatr Endocrinol. 2015;7:228–234. doi:10.4274/jcrpe.1867
  • Yu S, Yang H, Guo X, et al. Prevalence of dyslipidemia and associated factors among the hypertensive population from rural Northeast China. BMC Public Health. 2015;15:1152. doi:10.1186/s12889-015-2486-7
  • Li Z, Yang R, Xu G, et al. Serum lipid concentrations and prevalence of dyslipidemia in a large professional population in Beijing. Clin Chem. 2005;51:144–150.
  • Azizi F, Rahmani M, Ghanbarian A, et al. Serum lipid levels in an Iranian adults population: tehran Lipid and Glucose Study. Eur J Epidemiol. 2003;18:311–319. doi:10.1023/A:1023606524944
  • Aguilar-Salinas CA, Olaiz G, Valles V, et al. High prevalence of low HDL cholesterol concentrations and mixed hyperlipidemia in a Mexican nationwide survey. J Lipid Res. 2001;42:1298–1307.
  • Erem C, Hacihasanoglu A, Deger O, et al. Prevalence of metabolic syndrome and associated risk factors among Turkish adults: trabzon MetS study. Endocrine. 2008;33:9–20. doi:10.1007/s12020-008-9044-3
  • Fan Y, Huang -J-J, Sun C-M, et al. Prevalence of dyslipidaemia and risk factors in Chinese coal miners: a cross-sectional survey study. Lipids Health Dis. 2017;16:161. doi:10.1186/s12944-017-0548-9
  • Sharma U, Kishore J, Garg A, et al. Dyslipidemia and associated risk factors in a resettlement colony of Delhi. J Clin Lipidol. 2013;7:653–660. doi:10.1016/j.jacl.2013.06.003
  • de Souza LJ, Souto Filho JT, de Souza TF, et al. Prevalence of dyslipidemia and risk factors in Campos dos Goytacazes, in the Brazilian state of Rio de Janeiro. Arq Bras Cardiol. 2003;81:249–264. doi:10.1590/S0066-782X2003001100005
  • Houston MC, Basile J, Bestermann WH, et al. Addressing the global cardiovascular risk of hypertension, dyslipidemia, and insulin resistance in the southeastern United States. Am J Med Sci. 2005;329:276–291. doi:10.1097/00000441-200506000-00008
  • Betteridge DJ. Diabetic dyslipidemia. Diab Obes Metab. 2000;1:31–36. doi:10.1046/j.1463-1326.2000.00021.x
  • Mirrakhimov EM, Kerimkulova AS, Lunegova OS, et al. The association of leptin with dyslipidemia, arterial hypertension and obesity in Kyrgyz (central Asian nation) population. BMC Res Notes. 2014;7:411.
  • Shen Z, Munker S, Wang C, et al. Association between alcohol intake, overweight, and serum lipid levels and the risk analysis associated with the development of dyslipidemia. J Clin Lipidol. 2014;8:273–278. doi:10.1016/j.jacl.2014.02.003
  • Calle EE, Thun MJ, Petrelli JM, et al. Body mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med. 1999;341:1097–1105. doi:10.1056/NEJM199910073411501
  • Klop B, Elte JW, Cabezas MC. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients. 2013;5:1218–1240.
  • National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III) final report. Circulation. 2002;106:3143–3421.
  • Dixon JB, O’Brien PE. Lipid profile in the severely obese: changes with weight loss after lap-band surgery. Obes Res. 2002;10:903–910. doi:10.1038/oby.2002.124
  • Qi L, Ding X, Tang W, et al. Prevalence and risk factors associated with dyslipidemia in Chongqing, China. Inter J Env Res Pub Heal. 2015;12:13455–13465. doi:10.3390/ijerph121013455
  • Ozder A. Lipid profile abnormalities seen in t2dm patients in primary healthcare in turkey: a cross-sectional study. Lipids Health Dis. 2014;13:183. doi:10.1186/1476-511X-13-183
  • Al-Hazzaa HM. The public health burden of physical inactivity in Saudi Arabia. J Family Community Med. 2004;11:45–51.
  • Moradi-Lakeh M, El Bcheraoui C, Tuffaha M, et al. The health of Saudi youths: current challenges and future opportunities. BMC Fam Pract. 2016;17:26. doi:10.1186/s12875-016-0425-z
  • Colberg SR, Sigal RJ, Fernhall B, et al. Exercise and type 2 diabetes: the american college of sports medicine and the american diabetes association: joint position statement. Diab Care. 2010;33:e147–e167. doi:10.2337/dc10-9990